Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy

Michael I. D’Angelica(Memorial Sloan Kettering Cancer Center), Clifford Y. Ko(University of California, Los Angeles), Matthew Dixon(Rush University Medical Center), Rebecca A. Snyder(The University of Texas MD Anderson Cancer Center), Carlos Fernández‐del Castillo(Massachusetts General Hospital), Bradley N. Reames(University of Nebraska Medical Center), John C. McAuliffe(Albert Einstein College of Medicine), Shishir K. Maithel(Emory University Hospital), Sepideh Gholami(University of California, Davis), Pablo E. Serrano(McMaster University), Umut Sarpel(Mount Sinai Medical Center), Marina Talamonti(NorthShore University HealthSystem), Dominic E. Sanford(The University of Queensland), Mithat Gönen(Memorial Sloan Kettering Cancer Center), Mark E. Cohen(American College of Surgeons), Emily C. Zabor(Memorial Sloan Kettering Cancer Center), Courtney L. Scaife(Huntsman Cancer Institute), Mark J. Ott(Intermountain Healthcare), Carlos H.F. Chan(University of Iowa Hospitals and Clinics), Travis Smith(Gundersen Health System), Harish Lavu(Thomas Jefferson University), Brian C. Brajcich(American College of Surgeons), Scott Celinski(Baylor University Medical Center), Stephen W. Behrman(Baptist Memorial Hospital), Michael G. House(Indiana University – Purdue University Indianapolis), Ryan J. Ellis(Memorial Sloan Kettering Cancer Center), Vanessa Thompson(American College of Surgeons), Paul J. Karanicolas(Sunnybrook Health Science Centre), Jason B. Liu(Brigham and Women's Hospital), Adam C. Yopp(Southwestern Medical Center), Mary Dillhoff(The Ohio State University), Sharon M. Weber(University of Wisconsin–Madison), Kimberly A. Bertens(University of Ottawa), Henry A. Pitt(Barnes-Jewish Hospital), Susan K. Seo(Memorial Sloan Kettering Cancer Center), David J. Bentrem(Northwestern University), Michele Babicky(Providence Portland Medical Center)
JAMA
April 20, 2023
Cited by 121


Related Papers